公开(公告)号：US5017499A

公开(公告)日：1991-05-21

申请号：US330898

申请日：1989-03-31

申请人： Kohzo Hakuta ,  Minoru Aramaki ,  Takashi Suenaga ,  Mitsuo Kodama ,  Hisaji Nakano ,  Shinsuke Nakagawa

发明人： Kohzo Hakuta ,  Minoru Aramaki ,  Takashi Suenaga ,  Mitsuo Kodama ,  Hisaji Nakano ,  Shinsuke Nakagawa

IPC分类号： G01N31/00 ,  G01N33/00 ,  H01S3/104 ,  H01S3/225

CPC分类号： H01S3/104 ,  G01N31/005 ,  G01N33/0052 ,  H01S3/225 ,  Y10T436/12 ,  Y10T436/19 ,  Y10T436/204998 ,  Y10T436/207497

摘要： The concentration of molecular fluorine in a mixed gas such as an excimer laser gas can be determined easily, quickly and accurately by passing the mixed gas through a column packed with an alakli metal or alkaline earth metal compound which has no halogen atom and reacts with fluorine to form a solid fluoride together with molecular oxygen and/or carbon dioxide and measuring the concentration of oxygen or carbon dioxide in the fluorine-free gas flowed out of the packed column. If the mixed gas initially contains molecular oxygen or carbon dioxide, its concentration is measured separately after fixing fluorine in another column packed with an element which forms a fluoride. This analyzing method can be used in a feedback control system for controlling the concentration of fluorine in an excimer laser gas during operation of the laser to thereby stabilize the laser output power.

摘要翻译： 混合气体如准分子激光气体中的分子氟的浓度可以通过使混合气体通过填充有不含卤素原子并与氟反应的碱金属或碱土金属化合物的柱而容易，准确地测定 与分子氧和/或二氧化碳一起形成固体氟化物，并测量从填充塔流出的无氟气体中的氧气或二氧化碳的浓度。 如果混合气体最初含有分子氧或二氧化碳，则在将氟固定在填充有形成氟化物的元素的另一柱中后，分别测量其浓度。 该分析方法可以用于反馈控制系统，用于在激光器的操作期间控制准分子激光气体中的氟浓度，从而稳定激光输出功率。

公开(公告)号：US5149659A

公开(公告)日：1992-09-22

申请号：US666691

申请日：1991-03-05

申请人： Kohzo Hakuta ,  Minoru Aramaki ,  Takashi Suen. A ,  Mitsuo Kodama ,  Hisaji Nakano ,  Shinsuke Nakagawa

发明人： Kohzo Hakuta ,  Minoru Aramaki ,  Takashi Suen. A ,  Mitsuo Kodama ,  Hisaji Nakano ,  Shinsuke Nakagawa

IPC分类号： G01N31/00 ,  G01N33/00 ,  H01S3/104 ,  H01S3/225

CPC分类号： H01S3/104 ,  G01N31/005 ,  G01N33/0052 ,  H01S3/225 ,  Y10T436/12 ,  Y10T436/19 ,  Y10T436/204998 ,  Y10T436/207497

摘要： The concentration of molecular fluorine in a mixed gas such as an excimer laser gas can be determined easily, quickly and accurately by passing the mixed gas through a column packed with an alkali metal or alkaline earth metal compound which has no halogen atom and reacts with fluorine to form a solid fluoride together with molecular oxygen and/or carbon dioxide and measuring the concentration of oxygen or carbon dioxide in the fluorine-free gas flowed out of the packed column. If the mixed gas initially contains molecular oxygen or carbon dioxide, its concentration is measured separately after fixing fluorine in another column packed with an element which forms a fluoride. This analyzing method can be used in a feedback control system for controlling the concentration of fluorine in an excimer laser gas during operation of the laser to thereby stabilize the laser output power.

公开(公告)号：US4964137A

公开(公告)日：1990-10-16

申请号：US466930

申请日：1990-01-18

申请人： Minoru Aramaki ,  Shinsuke Nakagawa ,  Hisaji Nakano ,  Hiroshi Ichimura ,  Masahiro Tainaka

发明人： Minoru Aramaki ,  Shinsuke Nakagawa ,  Hisaji Nakano ,  Hiroshi Ichimura ,  Masahiro Tainaka

IPC分类号： H01S3/097 ,  H01S3/036 ,  H01S3/223 ,  H01S3/225

CPC分类号： H01S3/036 ,  H01S3/225

摘要： A laser gas used in a rare gas fluoride excimer laser is efficiently refined with little loss of the principal rare gas such as Ar, Kr or Xe by sequential contact of the laser gas first with a reactive metal, e.g. Si or Fe, for conversion of the fluorine source gas such as F.sub.2 or NF.sub.3 to a metal fluoride, then with a solid alkaline compound, e.g. Ca(OH).sub.2, for conversion of gaseous fluorides to solid metal fluorides, next with zeolite which is adsorbent of most of the remaining impurities and finally with an alkaline metal, e.g. Ca or Na, for decomposition of CF.sub.4 to form a solid metal fluoride and carbon. CF.sub.4 is formed during operation of the excimer laser by reaction of fluorine with a fluororesin used as electrical insulator in the laser apparatus, and accumulation of CF.sub.4 in the laser gas caused significal lowering of the laser output power.

摘要翻译： 在稀有气体氟化物准分子激光器中使用的激光气体通过先将激光气体与活性金属例如反应性金属顺序接触而有效地精制而不损失诸如Ar，Kr或Xe的主要稀有气体。 Si或Fe，用于将氟源气体如F2或NF3转化为金属氟化物，然后用固体碱性化合物，例如， Ca（OH）2，用于将气态氟化物转化为固体金属氟化物，接下来是沸石，其是大部分剩余杂质的吸附剂，最后是碱金属，例如碱金属。 Ca或Na，用于分解CF4以形成固体金属氟化物和碳。 在激光装置中通过氟与用作电绝缘体的氟树脂反应而在准分子激光器的操作期间形成CF4，并且CF4在激光气体中的积聚导致激光输出功率的显着降低。

公开(公告)号：US5817284A

公开(公告)日：1998-10-06

申请号：US738588

申请日：1996-10-29

申请人： Hisaji Nakano ,  Nobuhiko Matsuoka ,  Tetsuo Ueda ,  Shinsuke Nakagawa

发明人： Hisaji Nakano ,  Nobuhiko Matsuoka ,  Tetsuo Ueda ,  Shinsuke Nakagawa

IPC分类号： B01D53/68 ,  B01D53/70

CPC分类号： B01D53/70 ,  B01D53/68 ,  B01D2251/306 ,  B01D2251/604 ,  Y02C20/30

摘要： The present invention relates to a method for decomposing any of chlorocarbons, chlorofluorocarbons, perfluorocarbons and SF.sub.6 contained in a gas. This method includes the step of bringing the gas into contact, at a temperature of at least 300.degree. C., with a first mixture consisting essentially of 0.05-40 wt % of potassium hydroxide and at least one compound selected from the group consisting of alkali-earth-metal oxides and alkali-earth-metal hydroxides, for decomposing the at least one halide compound. When the halide compound-containing gas further contains oxygen, this gas may be brought into contact, at a temperature of at least 500.degree. C., with at least one first substance selected from the group consisting of active carbon, iron powder and nickel powder, for removing the oxygen from the gas, prior to the halide compound decomposition. When the halide compound-containing gas still further contains a strong oxidizing gas (e.g., fluorine), this gas may be brought into contact, at a temperature of at least 300.degree. C., with at least one second substance selected from the group consisting of Si, Ti, Ge, W, Mo, Fe, Mn, Co, Zn, Sn, B, Zr and compounds of these elements, except oxides of these elements, such that the oxidizing gas turns into a compound that is not reactive with the at least one first substance. According to this method, it is possible to decompose halide compounds contained within a gas, using a smaller equipment, at a lower temperature, as compared with conventional methods.

摘要翻译： 本发明涉及分解气体中所含的氯碳烃，氯氟烃，全氟化碳和SF 6中的任何一种的方法。 该方法包括在至少300℃的温度下使气体与基本上由0.05-40重量％的氢氧化钾和至少一种选自碱金属的化合物组成的第一混合物接触的步骤 - 金属氧化物和碱土金属氢氧化物，用于分解至少一种卤化物。 当含卤化物的气体还含有氧气时，该气体可以在至少500℃的温度下与至少一种选自活性炭，铁粉和镍粉末的第一物质接触 用于在卤化物分解之前从气体中除去氧气。 当含卤化物的气体还含有强氧化气体（例如氟）时，该气体可以在至少300℃的温度下与至少一种选自以下的第二物质接触： Si，Ti，Ge，W，Mo，Fe，Mn，Co，Zn，Sn，B，Zr和这些元素的化合物，除了这些元素的氧化物以外，使得氧化气体变成与 所述至少一种第一物质。 根据该方法，与常规方法相比，可以使用较小的设备在较低温度下分解包含在气体中的卤化物化合物。

公开(公告)号：US10905694B2

公开(公告)日：2021-02-02

申请号：US12665642

申请日：2008-06-20

申请人： Shinsuke Nakagawa ,  Kai Suzuki ,  Tadashi Mukai

发明人： Shinsuke Nakagawa ,  Kai Suzuki ,  Tadashi Mukai

IPC分类号： A61K31/55 ,  A61K9/20 ,  A61K9/16

摘要： The subject invention provides a novel pharmaceutical solid preparation that has superior disintegration properties and excellent solubility, leading to sufficient absorbability of active ingredients through the gastrointestinal tract. The pharmaceutical solid preparation of the present invention comprises: (a) 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzoazepine and/or salt thereof; (b) hydroxypropylcellulose containing a hydroxypropoxyl group in an amount of 50% or greater; and (c) at least one member selected from the group consisting of carmellose, sodium carboxy methyl starch, crospovidone, and low substituted hydroxypropylcellulose with an average particle diameter of 30 to 70 μm, and a 90% cumulative particle diameter of 100 to 200 μm.

公开(公告)号：US20110141614A1

公开(公告)日：2011-06-16

申请号：US12963111

申请日：2010-12-08

申请人： Kenji Suzuki ,  Shinsuke Nakagawa ,  Toshihiko Shimizu ,  Eiji Soga ,  Takaaki Deguchi ,  Mutsuro Ohta

发明人： Kenji Suzuki ,  Shinsuke Nakagawa ,  Toshihiko Shimizu ,  Eiji Soga ,  Takaaki Deguchi ,  Mutsuro Ohta

IPC分类号： G11B21/02 ,  G11B5/54

CPC分类号： G11B5/4833 ,  G11B5/4813 ,  G11B5/4873

摘要： A magnetic head drive device including a suspension for supporting a magnetic head, and a main actuator that produces rotary movement of the magnetic head by applying current to a coil. The main actuator includes end arms each comprising a single micro-actuator, and an intermediate arm comprising two micro-actuators. The micro-actuators of the end arms are driven in the same direction, and the micro-actuators of the intermediate arm are driven in the opposite direction to the drive direction of the micro-actuators of said the arms.

摘要翻译： 一种磁头驱动装置，包括用于支撑磁头的悬架，以及通过向线圈施加电流来产生磁头的旋转运动的主致动器。 主致动器包括各自包括单个微致动器的端臂和包括两个微致动器的中间臂。 端臂的微致动器沿相同的方向被驱动，并且中间臂的微致动器沿与所述臂的微致动器的驱动方向相反的方向被驱动。

公开(公告)号：US20130027814A1

公开(公告)日：2013-01-31

申请号：US13193831

申请日：2011-07-29

申请人： Kenji Suzuki ,  Mutsuro Ohta ,  Takaaki Deguchi ,  Fu-Ying Huang ,  Shinsuke Nakagawa

发明人： Kenji Suzuki ,  Mutsuro Ohta ,  Takaaki Deguchi ,  Fu-Ying Huang ,  Shinsuke Nakagawa

IPC分类号： G11B5/56 ,  H02K41/035

CPC分类号： H02K41/0358 ,  G11B5/4833 ,  G11B5/486 ,  H02K3/26 ,  H02K2203/03

摘要： A flexible-printed-circuit (FPC) voice-coil assembly configured for integration in a voice-coil motor. The FPC voice-coil assembly includes at least one FPC voice coil. The FPC voice coil includes a coil including at least one coil turn, and a flexible substrate. The flexible substrate is coupled to the coil to form a flexible printed circuit. The FPC voice coil is configured for integration in a voice-coil motor. A voice-coil motor and a disk drive including the FPC voice-coil assembly are also provided.

摘要翻译： 配置为集成在音圈电机中的柔性印刷电路（FPC）音圈组件。 FPC音圈组件包括至少一个FPC音圈。 FPC音圈包括包括至少一个线圈匝的线圈和柔性基板。 柔性基板耦合到线圈以形成柔性印刷电路。 FPC音圈配置成集成在音圈电机中。 还提供了一种音圈电动机和包括FPC音圈组件的磁盘驱动器。

公开(公告)号：US20100273200A1

公开(公告)日：2010-10-28

申请号：US12086351

申请日：2006-12-18

申请人： Masami Niwa ,  Shinsuke Nakagawa ,  Maria Anna Deli

发明人： Masami Niwa ,  Shinsuke Nakagawa ,  Maria Anna Deli

IPC分类号： C12Q1/02 ,  C12N11/00

CPC分类号： C12M35/08 ,  C12N5/0691 ,  C12N2502/28 ,  C12N2533/52 ,  C12N2533/54 ,  G01N33/5058 ,  G01N33/5064 ,  G01N33/5091

摘要： It is intended to provide a screening system for a centrally acting drug transported across the blood-brain barrier, a drug acting on the blood-brain barrier itself, or a drug transferred into the brain without being expected to centrally act. Moreover, another object of the present invention is to achieve pathogenesis analysis study or the screening in a diseased state by applying various diseased environments to this screening system. The present invention provides an in-vitro model of blood-brain barrier obtained by using a three-dimensional culture apparatus comprising: a culture solution; a plate holding the culture solution; and a filter immersed in the culture solution and placed in no contact with the inside bottom of the plate, the filter having plural pores of 0.35 to 0.45 μm in diameter, and by comprising: seeding primary cultured brain capillary endothelial cells onto the upper surface of the filter; seeding primary cultured brain pericytes onto the under surface of the filter; seeding primary cultured astrocytes onto the inside surface of the plate; and coculturing these cells in a normal culture solution.

摘要翻译： 旨在提供一种用于跨血脑屏障运输的中枢作用药物的筛选系统，作用于血脑屏障本身的药物或转移到大脑中的药物，而不预期集中起作用。 此外，本发明的另一个目的是通过在该筛选系统中应用各种疾病环境来实现发病机理分析研究或疾病筛查。 本发明提供通过使用三维培养装置获得的血脑屏障的体外模型，所述三维培养装置包括：培养液; 持有培养液的板块; 将浸渍在培养液中的过滤器与板的内部底部不接触地配置，该过滤器具有直径为0.35〜0.45μm的多个孔，并且包括：将原代培养的脑毛细血管内皮细胞接种到 过滤器 将原代培养的脑周细胞接种到过滤器的下表面上; 将原代培养的星形胶质细胞接种在板的内表面上; 并在正常培养溶液中共培养这些细胞。

公开(公告)号：US06770253B2

公开(公告)日：2004-08-03

申请号：US10238041

申请日：2002-09-10

申请人： Shinsuke Nakagawa ,  Takaaki Shibayama ,  Atsushi Ryokawa ,  Hisakazu Itoh

发明人： Shinsuke Nakagawa ,  Takaaki Shibayama ,  Atsushi Ryokawa ,  Hisakazu Itoh

IPC分类号： C01B3308

CPC分类号： C01B33/10705

摘要： A process for producing silicon tetrafluoride includes reacting at 250° C. or higher elemental silicon with hydrogen fluoride, thereby producing a gas product containing silicon tetrafluoride. This reaction can be conducted such that the gas product contains at least 0.02 volume % of the unreacted hydrogen fluoride. The process may further include bringing the gas product into contact with elemental nickel at a temperature of 600° C. or higher. Alternatively, the process may further include adding at least 0.1 volume % of hydrogen fluoride to the gas product to prepare a gas mixture; and bringing the gas mixture into contact with elemental nickel at a temperature of 400° C. or higher.

摘要翻译： 制造四氟化硅的方法包括在250℃或更高的元素硅与氟化氢反应，从而产生含有四氟化硅的气体产物。 该反应可以进行，使得气体产物含有至少0.02体积％的未反应氟化氢。 该方法还可以包括使气体产物在600℃或更高的温度下与元素镍接触。 或者，该方法还可以包括向气体产物中加入至少0.1体积％的氟化氢以制备气体混合物; 并在400℃或更高的温度下使气体混合物与元素镍接触。

公开(公告)号：US5969156A

公开(公告)日：1999-10-19

申请号：US945812

申请日：1997-09-29

申请人： Christopher A. Briggs ,  Rex A. Jennings ,  Robert Wade ,  Kikuko Harasawa ,  Shigeru Ichikawa ,  Kazuo Minohara ,  Shinsuke Nakagawa

发明人： Christopher A. Briggs ,  Rex A. Jennings ,  Robert Wade ,  Kikuko Harasawa ,  Shigeru Ichikawa ,  Kazuo Minohara ,  Shinsuke Nakagawa

IPC分类号： C07D207/34 ,  A61K31/00 ,  A61K31/40 ,  A61P3/06 ,  A61P3/14 ,  A61P43/00 ,  C07D20060101 ,  C07D207/335 ,  A01N43/36

CPC分类号： C07D207/34

摘要： Crystalline forms of atorvastatin and hydrates thereof are useful hypolipidemic and hypocholesterolemic agents.

摘要翻译： PCT No.PCT / US96 / 11368 Sec。 371 1997年10月2日第 102（e）日期1997年10月2日PCT PCT 1996年7月8日PCT公布。 公开号WO97 / 03959 日期1997年2月6日阿托伐他汀及其水合物的结晶形式是降血脂和降血胆固醇药物。